Sirolimus-related systemic thrombotic microangiopathy after renal transplantation.
We describe the case of a renal transplant patient who developed de novo biopsy-proven thrombotic microangiopathy (TMA) and deep venous thrombosis after treatment with sirolimus (SRL). We discuss the clinical course, diagnosis and therapeutics of this patient in the context of the literature.